Table 3.
Univariate and multivariate analysis of factors predictive of mortality in COVID-19 patients.
| Characteristic | Mortality | |||
|---|---|---|---|---|
| Unadjusted OR (95% CI) | p-Value | Adjusted OR (95% CI) | p-Value | |
| Age | 1.06 (1.04–1.09) | <0.001 | 1.08 (1.03–1.14) | 0.003 |
| Lab at admission | ||||
| Serum Cr | 1.16 (1.02–1.33) | 0.029 | 1.20 (0.96–1.51) | 0.111 |
| Hemoglobin | 0.80 (0.70–0.90) | <0.001 | 0.90 (0.72–1.14) | 0.386 |
| Serum albumin | 0.41 (0.22–0.75) | 0.004 | 1.02 (0.36–2.91) | 0.973 |
| Serum ferritin | 1.00 (1.00–1.00) | 0.045 | 1.00 (0.99–1.00) | 0.008 |
| CRP | 1.00 (1.00–1.03) | 0.849 | ||
| Acidemia | 1.66 (0.76–3.64) | 0.205 | ||
| Lactate level | 1.05 (1.02–1.09) | 0.002 | 1.05 (0.99–1.10) | 0.103 |
| Nephrotoxins | 1.58 (0.77–3.24) | 0.213 | ||
| AKD | 7.27 (3.71–14.25) | <0.001 | 3.19 (1.18–8.58) | 0.022 |
AKI, acute kidney injury; ARDS, acute respiratory distress syndrome; CRP, c-reactive protein; CKD, chronic kidney disease; CVD, cardiovascular disease; COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; GFR, glomerular filtration rate; Lab, laboratory; NL, neutrophil and lymphocyte; RRT, renal replacement therapy; RAAS, renin angiotensin aldosterone system; SCR, serum creatinine; SOFA, sequential organ failure assessment.